Report:

FDA Inspection Fiscal Year (FY) 2023 Annual Report: Top 3 Citation Categories Related To Drugs  

FDA Inspection Fiscal Year (FY) 2023 Annual Report: Top 3 Citation Categories Related To Drugs

We analyzed the drug-related citations in the Fiscal Year (FY) 2023 Annual Report from the Office of Compliance paying specific attention to the broader examination of initiatives such as inspections, quality control, and adherence to Good Manufacturing Practice (GMP) standards.

Download the report to learn:

  • What are the top 3 citations related to drugs, excluding food and OTC products

  • How QMS digitalization can mitigate these areas

  • How QMS digitalization can help companies achieve better Quality Management Maturity (QMM) according to the FDA program.